Dyania Health and Nvidia Partner to Expand AI Use in Clinical Trials, Boosting Patient Enrollment and Speed
Dyania Health has announced a partnership with Nvidia to expand the use cases for its Synapsis AI platform in clinical trials. This collaboration aims to accelerate clinical trial recruitment and improve efficiency. Dyania Health's Synapsis AI platform reads patient longitudinal records to answer clinical questions, providing evidence for eligibility assessments. Nvidia's accelerated computing capabilities enable this process to scale across large patient populations while keeping data secure within hospital firewalls. The Cleveland Clinic, which has invested in Dyania Health, deployed Synapsis AI across its enterprise in November 2025. Since its deployment, study teams utilizing the platform have reported a 40% increase in patient enrollment and a 47% faster recruitment process. This successful implementation also earned the collaboration a 2026 Gartner Eye on Innovation Award, highlighting its significant impact on getting patients into studies more efficiently.